P.R. Elford

1.4k total citations
24 papers, 1.2k citations indexed

About

P.R. Elford is a scholar working on Molecular Biology, Rheumatology and Oncology. According to data from OpenAlex, P.R. Elford has authored 24 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Rheumatology and 5 papers in Oncology. Recurrent topics in P.R. Elford's work include Bone Metabolism and Diseases (9 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Cell Adhesion Molecules Research (5 papers). P.R. Elford is often cited by papers focused on Bone Metabolism and Diseases (9 papers), Osteoarthritis Treatment and Mechanisms (7 papers) and Cell Adhesion Molecules Research (5 papers). P.R. Elford collaborates with scholars based in Switzerland, United Kingdom and Japan. P.R. Elford's co-authors include H. Fleisch, Marco Cecchini, U. Trechsel, R. Felix, Franco E. Di Padova, Jean H.M. Feyen, Willy Hofstetter, Philip H. Cooper, R.G.G. Russell and J. E. Meats and has published in prestigious journals such as FEBS Letters, Endocrinology and Journal of Bone and Mineral Research.

In The Last Decade

P.R. Elford

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.R. Elford Switzerland 18 678 448 321 241 136 24 1.2k
Ryotaro Iwasaki Japan 14 587 0.9× 381 0.9× 218 0.7× 180 0.7× 159 1.2× 21 1.0k
Rasesh Kapadia United States 13 612 0.9× 428 1.0× 320 1.0× 94 0.4× 237 1.7× 15 1.0k
Joseph A. Lorenzo United States 21 906 1.3× 642 1.4× 132 0.4× 172 0.7× 264 1.9× 31 1.4k
Manali Bendre United States 7 551 0.8× 578 1.3× 99 0.3× 121 0.5× 88 0.6× 8 990
Takuo Juji Japan 12 539 0.8× 382 0.9× 500 1.6× 134 0.6× 125 0.9× 28 996
Uriel M. Malyankar United States 10 477 0.7× 263 0.6× 106 0.3× 116 0.5× 73 0.5× 12 920
K. Yamaguchi Japan 10 835 1.2× 591 1.3× 143 0.4× 83 0.3× 259 1.9× 22 1.2k
Sandrine Théoleyre France 16 901 1.3× 763 1.7× 159 0.5× 165 0.7× 202 1.5× 25 1.4k
Dan Georgess United States 11 427 0.6× 260 0.6× 426 1.3× 168 0.7× 98 0.7× 16 1.0k
Adelheid Korb Germany 8 950 1.4× 482 1.1× 1.1k 3.4× 491 2.0× 232 1.7× 9 2.0k

Countries citing papers authored by P.R. Elford

Since Specialization
Citations

This map shows the geographic impact of P.R. Elford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.R. Elford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.R. Elford more than expected).

Fields of papers citing papers by P.R. Elford

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.R. Elford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.R. Elford. The network helps show where P.R. Elford may publish in the future.

Co-authorship network of co-authors of P.R. Elford

This figure shows the co-authorship network connecting the top 25 collaborators of P.R. Elford. A scholar is included among the top collaborators of P.R. Elford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.R. Elford. P.R. Elford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elford, P.R., et al.. (2013). Biodistribution and predictive hepatic gene expression of intravenous iron sucrose. Journal of Pharmacological and Toxicological Methods. 68(3). 374–383. 11 indexed citations
2.
Meier, Thomas, et al.. (2011). Physicochemical and toxicological characterization of a new generic iron sucrose preparation. Arzneimittelforschung. 61(2). 112–119. 18 indexed citations
3.
Elford, P.R., Richard Heng, Láśzló Révész, & Andrew MacKenzie. (1995). Reduction of inflammation and pyrexia in the rat by oral administration of SDZ 224‐015, an inhibitor of the interleukin‐1β converting enzyme. British Journal of Pharmacology. 115(4). 601–606. 18 indexed citations
5.
Russell, R.G.G., Fraser P. Coxon, Henrik Skjødt, et al.. (1992). Cyclosporin A. Mode of Action and Effects on Bone and Joint Tissues. Scandinavian Journal of Rheumatology. 21(sup95). 9–18. 24 indexed citations
6.
Pozo, Emilio del, et al.. (1992). Prevention of adjuvant arthritis by cyclosporine in rats. Seminars in Arthritis and Rheumatism. 21(6). 23–29. 15 indexed citations
7.
Elford, P.R. & Philip H. Cooper. (1991). Induction of neutrophil‐mediated cartilage degradation by interleukin‐8. Arthritis & Rheumatism. 34(3). 325–332. 62 indexed citations
8.
Bollinger, Pietro, et al.. (1991). Pharmacological effects of a new antiarthritic agent, IX 207-887.. PubMed. 30 Suppl 2. 75–8. 3 indexed citations
9.
Elford, P.R. & S.W.J. Lamberts. (1990). Contrasting Modulation by Transforming Growth Factor-β-1 of Insulin-Like Growth Factor-I Production in Osteoblasts and Chondrocytes. Endocrinology. 127(4). 1635–1639. 36 indexed citations
10.
Pozo, E. del, Manuel B. Graeber, P.R. Elford, & T.G. Payne. (1990). Regression of bone and cartilage loss in adjuvant arthritic rats after treatment with cyclosporin a. Arthritis & Rheumatism. 33(2). 247–252. 46 indexed citations
11.
Felix, R., H. Fleisch, & P.R. Elford. (1989). Bone-resorbing cytokines enhance release of macrophage colony-stimulating activity by the osteoblastic cell MC3T3-E1. Calcified Tissue International. 44(5). 356–360. 72 indexed citations
12.
Feyen, Jean H.M., Franco E. Di Padova, U. Trechsel, & P.R. Elford. (1989). Interleukin-6 is produced by bone and modulated by parathyroid hormone. Journal of Bone and Mineral Research. 4(4). 633–638. 199 indexed citations
13.
Guenther, Harald L., Marco Cecchini, P.R. Elford, & H. Fleisch. (1988). Effects of transforming growth factor type beta upon bone cell populations grown either in monolayer or semisolid medium. Journal of Bone and Mineral Research. 3(3). 269–278. 35 indexed citations
14.
Elford, P.R., R. Felix, Marco Cecchini, U. Trechsel, & H. Fleisch. (1987). Murine osteoblastlike cells and the osteogenic cell MC3T3-E1 release a macrophage colony-stimulating activity in culture. Calcified Tissue International. 41(3). 151–156. 87 indexed citations
15.
Elford, P.R., Harald L. Guenther, R. Felix, Marco Cecchini, & H. Fleisch. (1987). Transforming growth factor-β reduces the phenotypic expression of osteoblastic MP3T3-E1 cells in monolayer culture. Bone. 8(4). 259–262. 54 indexed citations
16.
Meats, J. E., P.R. Elford, R.A.D. Bunning, & R.G.G. Russell. (1985). Retinoids and synovial factor(s) stimulate the production of plasminogen activator by cultured human chondrocytes. A possible role for plasminogen activator in the resorption of cartilage in vitro. Biochimica et Biophysica Acta (BBA) - General Subjects. 838(1). 161–169. 29 indexed citations
17.
Elford, P.R., J. E. Meats, R. M. Sharrard, & R.G.G. Russell. (1985). Partial purification of a factor from human synovium that possesses interleukin 1, chondrocyte stimulating and catabolin‐like activities. FEBS Letters. 179(2). 247–251. 15 indexed citations
18.
Elford, P.R., et al.. (1985). Modulation of connective tissue metabolism by partially purified human interleukin 1. Cellular Immunology. 90(1). 41–51. 44 indexed citations
19.
Bunning, R.A.D., et al.. (1985). The Effects of Mononuclear Cell Factor/Interleukin-1 on the Plasminogen Activators Produced by Human Chondrocytes. Lara D. Veeken. XXIV(suppl 1). 118–121. 5 indexed citations
20.
Gowen, Maxine, et al.. (1984). Effects of glucocorticoids and anabolic steroids on cells derived from human skeletal and articular tissues in vitro.. PubMed. 171. 279–91. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026